Christopher S Henney Cyclacel Pharmaceuticals, Inc. (CYCC) insider trading activity

Christopher S Henney is Director of Cyclacel Pharmaceuticals, Inc.. Currently has a direct ownership of 39,415 shares of CYCC, which is worth approximately $39,809. The most recent transaction as insider was on Jun 30, 2023, when has been sold 21,219 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.4K

0% 3M change

0% 12M change

Total Value Held $39,809

CHRISTOPHER S HENNEY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 30 2023	BUY Grant, award, or other acquisition	-	21,219 Added 35.0%	39,415 Common Stock
Jun 14 2022	BUY Grant, award, or other acquisition	-	15,822 Added 46.51%	18,196 Common Stock
Jun 15 2021	BUY Grant, award, or other acquisition	-	2,374 Added 50.0%	2,374 Common Stock

Also insider at

PRTA

PROTHENA CORP PUBLIC LTD CO Healthcare

Director

CSH